Drugs & Therapy Perspectives

, Volume 19, Issue 7, pp 4–6 | Cite as

Imatinib Mesylate in GIST: profile report

  • Ian Judson
  • Allan van Oosterom
Drugs and Profile Reports


Imatinib Chronic Myeloid Leukaemia Imatinib Mesylate Metastatic Gist Dermatofibrosarcoma Protuberans 


  1. 1.
    Croom KF, Perry CM. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours. Drugs 2003; 63(5): 513–22PubMedCrossRefGoogle Scholar
  2. 2.
    Judson I. Imatinib mesylate: a viewpoint by Ian Judson. Drugs 2003; 63(5): 523CrossRefGoogle Scholar
  3. 3.
    Van Oosterom A. Imatinib mesylate: a viewpoint by Allan van Oosterom. Drugs 2003; 63(5): 523–4CrossRefGoogle Scholar
  4. 4.
    Lyseng-Williamson K, Jarvis B. Imatinib. Drugs 2001; 61(12): 1765–74; discussion 1775–6PubMedCrossRefGoogle Scholar
  5. 5.
    Buchdunger E, Cioffi CL, Law N, et al. Abl protein-tyrosine kinase inhibitor ST1571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther 2000; 295(1): 139–45PubMedGoogle Scholar
  6. 6.
    Druker BJ, Tamura S, Buchdunger E, et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 1996 May; 2: 561–6PubMedCrossRefGoogle Scholar
  7. 7.
    Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002 Aug 15; 347(7): 472–80PubMedCrossRefGoogle Scholar
  8. 8.
    van Oosterom AT, Judson IR, Verweij J, et al. Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumours: a report of the EORTC soft tissue and bone sarcoma group. Eur J Cancer 2002; 38 Suppl. 5: S83–7PubMedCrossRefGoogle Scholar
  9. 9.
    van Oosterom AT, Judson I, Verweij J, et al. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet 2001 Oct 27; 358(9291): 1421–3PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2003

Authors and Affiliations

  • Ian Judson
    • 1
  • Allan van Oosterom
    • 2
  1. 1.Sarcoma UnitRoyal Marsden HospitalLondonUK
  2. 2.Department of Clinical OncologyLeuven University HospitalLeuvenBelgium

Personalised recommendations